Adrenergic drugs in the treatment of hypertension.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001795:Blood Pressure Determination; D002740:Chlorothiazide / Q000627:therapeutic use; D005500:Follow-Up Studies; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality; D008750:Methyldopa / Q000627:therapeutic use; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D005730:Ganglionic Blockers; D013565:Sympatholytics; D008750:Methyldopa; D002740:Chlorothiazide; D011433:Propranolol; D006145:Guanethidine